Abstract
摘要
相似文献
1
ADR-529 (ICRF-187).ADR - 529（ICRF - 187）
Cancer Invest. 1989;7(1):101.
2
[Clinical experiences with radiotherapy and ICRF 159 in sarcomas].[肉瘤放疗与ICRF 159的临床经验]
Strahlentherapie Sonderb. 1978;75:110-4.
3
ICRF-187 and razoxane in cancer treatment.ICRF - 187与丙亚胺在癌症治疗中的应用
Lancet. 1987 Sep 26;2(8561):721.
4
5
Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.美法仑、ICRF - 159和羟基脲治疗转移性前列腺癌的评估：初步报告。
Cancer Treat Rep. 1977 Mar-Apr;61(2):311-2.
6
ICRF-187 in clinical oncology.临床肿瘤学中的ICRF - 187
Cancer Clin Trials. 1981;4(2):143-6.
7
Treatment of advanced adenocarcinoma of the kidney with ICRF-187: a Southeastern Cancer Study Group Trial.用ICRF - 187治疗晚期肾腺癌：一项东南癌症研究组试验
Cancer Treat Rep. 1986 Jul;70(7):915-6.
8
Phase II study of ICRF-159 in non-Hodgkin's lymphomas.ICRF-159用于非霍奇金淋巴瘤的II期研究。
Cancer Treat Rep. 1978 Mar;62(3):465-7.
9
10
A trial of razoxane (ICRF-159) in patients with prior therapy for Hodgkin's lymphoma.对曾接受过治疗的霍奇金淋巴瘤患者进行丙亚胺（ICRF - 159）试验。
Cancer. 1984 Oct 15;54(8):1496-8. doi: 10.1002/1097-0142(19841015)54:8<1496::aid-cncr2820540803>3.0.co;2-4.
Zotero 插件